What Is Glucagon? A Guide to Peptide Product Composition
Published: July 15, 2026 17:36
Author: Masahiro Barrett
Abstract: Glucagon, a 29-amino-acid peptide hormone, is critical in glucose homeostasis. This guide analyzes its synthetic composition, contrasting rapid-acting analogs (e.g., dasiglucagon) against traditional recombinant forms. Current market trends show a CAGR of 8.5% (2023-2030), driven by diabetic emergency kits and obesity research. Leading brands (Novo Nordisk, Xeris) differ in stability and delivery (auto-injectors vs. prefilled syringes). Technical advantages include rapid onset (10 min) vs. short shelf-life (24h reconstituted). Factory GMP certifications (FDA, EMA) are mandatory. Selection criteria prioritize purity (>98%) and cold-chain logistics (2-8°C). Industry outlook remains robust, with 45+ clinical trials ongoing.